Renovaro Biosciences Inc. (RENB) NASDAQ

0.32

+0.0111(+3.55%)

Updated at June 06 11:48AM

Currency In USD

Valuation

Market Cap150.15M
Enterprise Value153.71M
P/E Ratio-0.79
PEG Ratio-0.03
Price/Sales Ratio311.13
Price/Book Ratio0.6
Enterprise/Revenue344.79
Enterprise/EBITDA-0.58

Fiscal Year

Fiscal YearJune 30, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-369.28
Operating Margin-436.21

Management Effectiveness

Return On Assets-0.57
Return On Equity-0.67

Income Statement

Revenue0
Revenue/Share0
Gross Profit-121,859
EBITDA-81.52M
Net Income-80.65M
Diluted EPS-0.84

Balance Sheet

Total Cash923,002
Total Cash/Share0.01
Total Debt7.03M
Total Debt/Equity0.08
Current Ratio0.13
Book Value Per Share0.54

Price History

52-Week Change-75.34
52-Week High2.34
52-Week Low0.27
Moving Average 50 Days0.37
Moving Average 200 Days0.67

Statistics

Average Volume2.33M
Shares Outstanding172.12M
% Held by Institutions13.56

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A